Recent Advances in the Treatment of Huntington’s Disease: Targeting DNA and RNA

被引:0
|
作者
Kathleen M. Shannon
机构
[1] University of Wisconsin School of Medicine and Public Health,Department of Neurology
来源
CNS Drugs | 2020年 / 34卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Huntington’s disease is a dominantly inherited neurodegenerative disease caused by an unstable expanded trinucleotide repeat at the short end of the fourth chromosome. Central nervous system pathology begins in the striatum, eventually affecting the entire brain and occurs consequent to multiple intracellular derangements. The proximate cause is a mutant protein with an elongated polyglutamine tract. Pharmacological approaches targeting multiple domains of intracellular functions have universally been disappointing. However, recent developments in gene therapy, including antisense oligonucleotides, small interfering RNAs, and gene editing are bringing new hope to the Huntington’s community. This review discusses the promises and challenges of these new potential treatments.
引用
收藏
页码:219 / 228
页数:9
相关论文
共 50 条
  • [1] Recent Advances in the Treatment of Huntington's Disease: Targeting DNA and RNA
    Shannon, Kathleen M.
    [J]. CNS DRUGS, 2020, 34 (03) : 219 - 228
  • [2] Therapies targeting DNA and RNA in Huntington's disease
    Wild, Edward J.
    Tabrizi, Sarah J.
    [J]. LANCET NEUROLOGY, 2017, 16 (10): : 837 - 847
  • [3] Recent advances on the pathogenesis of Huntington's disease
    Petersén, Å
    Mani, K
    Brundin, P
    [J]. EXPERIMENTAL NEUROLOGY, 1999, 157 (01) : 1 - 18
  • [4] Recent advances in understanding the pathogenesis of Huntington's disease
    Reddy, PH
    Williams, M
    Tagle, DA
    [J]. TRENDS IN NEUROSCIENCES, 1999, 22 (06) : 248 - 255
  • [5] Recent Microscopy Advances and the Applications to Huntington's Disease Research
    Babi, Mouhanad
    Neuman, Kaitlyn
    Peng, Christina Y.
    Maiuri, Tamara
    Suart, Celeste E.
    Truant, Ray
    [J]. JOURNAL OF HUNTINGTONS DISEASE, 2022, 11 (03) : 269 - 280
  • [6] Recent advances in non-Huntington's disease choreas
    Cincotta, Molly C.
    Walker, Ruth H.
    [J]. PARKINSONISM & RELATED DISORDERS, 2024, 122
  • [7] Therapies targeting DNA and RNA in Huntington's disease (vol 16, pg 837, 2017)
    Wild, E. J.
    Tabrizi, S. J.
    [J]. LANCET NEUROLOGY, 2017, 16 (12): : 954 - 954
  • [8] Recent advances in imaging the onset and progression of Huntington's disease
    Scahill, Rachael
    [J]. NEURODEGENERATIVE DISEASE MANAGEMENT, 2013, 3 (03) : 241 - 252
  • [9] Recent advances in Huntington's disease: implications for experimental therapeutics
    Feigin, A
    Zgaljardic, D
    [J]. CURRENT OPINION IN NEUROLOGY, 2002, 15 (04) : 483 - 489
  • [10] Targeting Histone Deacetylases for the Treatment of Huntington's Disease
    Gray, Steven G.
    [J]. CNS NEUROSCIENCE & THERAPEUTICS, 2010, 16 (06) : 348 - 361